Pharmaceutical experience

Dr. Abato has developed qualified clinical candidates for Spinal Muscular Atrophy (SMA) and Multiple Sclerosis. As a Medicinal Chemist, Dr. Abato has also conducted research in the areas of Malaria, Tuberculosis and Cancer.

His expertise includes drug research, medicinal chemistry, organic chemistry, drug formulation for; IT, IV, IP, ICV, IN, IM and oral dosing routs, stability studies, extensive structure-activity relationships, efficacy, pharmacokinetics, as well as all pre clinical testing required for IND submission to the FDA.

Dr. Abato was awarded the prestigious “Heroes of Chemistry Award” by the American Chemical Society in 2019 for his contribution to NUZYRA, the latest antibiotic for antibacterial resistant bacterial infections.

Pharmaceutical Consulting

Dr Abato provides consulting services for medicinal chemistry, drug formulation, chemistry manufacturing and controls, literature search/summary and management of CROs. Dr Abato has consulted for a variety of pharmaceutical companies including the
Bill and Malinda Gates Medical Research Institution.

Expert witness consulting

Dr Abato has been involved in 8 cases, been deposed 5 times and has testified at trial on 4 occasions in a federal courts including at the ITC.

He has consulted for major players on the generic and branded side. Dr Abato is familiar with Hatch-Waxman / ANDA type litigation. He has also been involved with a high stakes trademark infringement case within the synthetic biology market space.

Download Dr Abato’s CV Here, which includes a complete list of case numbers, clients and Law Firms that he has consulted for.